Clinical trial shows pantethine improves psoriasis symptoms in 24 patients — Evidence Review

A recent study suggests that pantethine, a widely available nutritional supplement, may help reduce immune activity in psoriasis patients, especially those with elevated cholesterol. Related research generally supports the use of nutritional and metabolic interventions as adjunctive strategies for psoriasis, though evidence for any single supplement remains preliminary; see the original report from the State Key Laboratory of Biomedical Analysis for more details.

• Several studies have found that dietary and lifestyle changes, including supplementation (e.g., probiotics, prebiotics, omega-3 fatty acids), can modestly benefit psoriasis outcomes, usually as adjuncts to standard therapy, aligning with the pantethine findings 1 2 4.
• Past research on vitamin and nutrient supplementation (notably vitamin D) for psoriasis shows mixed results, with some promise in selected cases but no consistent improvements in clinical manifestations for the broader population 3 4 5.
• The mechanism explored in the new study—targeting metabolic pathways in immune cells—is less explored in existing research, which has more often focused on anti-inflammatory or microbiome-related interventions 1 2. This represents a novel angle, though more evidence is needed to confirm its clinical applicability.

Study Overview and Key Findings

Psoriasis is a chronic autoimmune skin disease marked by excessive inflammation, often managed with topical therapies and systemic medications. Despite advances, many patients continue to seek alternative or adjunctive treatments. The new study stands out for investigating pantethine, a vitamin B5 derivative commonly used to lower cholesterol, as a potential modulator of immune cell metabolism. By examining both animal models and a small randomized trial in humans, the researchers provide early evidence that metabolic interventions might modify immune function in psoriasis, which could represent a novel therapeutic avenue.

Property	Value
Study Year	2026
Organization	State Key Laboratory of Biomedical Analysis
Journal Name	Journal of Experimental Medicine
Authors	Ai-Ping Cao, Jun-Cheng Li, Rui Wang, Yun-Ying Wang, Nan Wu, Yan-Hong Liu, Zhi Jin, Jia-Yu Liu, Yan-Yan Shen, Yue Guo, Qi Qi, Yao Wang, Rui-Bo Wang, Bo-Yang Xie, Chun-Yan Yan, Qiu-Ying Han, Shao-Yi Huang, Sheng-Ming Wu, Na Wang, Xin Pan, Cheng-Xin Li, Tao Zhou, Ai-Ling Li, Qing Xia, Wei-Na Zhang
Population	Patients with psoriasis
Sample Size	24 patients
Methods	Randomized Controlled Trial (RCT)
Outcome	Psoriasis symptoms, immune system activity
Results	Participants taking pantethine showed symptom improvements.

Literature Review: Related Studies

To situate these findings in the context of broader research, we searched the Consensus paper database, which contains over 200 million research papers. The following search queries were used:

1. pantethine psoriasis symptom improvement
2. nutritional supplements psoriasis treatment
3. pantethine mechanism psoriasis effects

Below is a summary of related studies, grouped by major research topics:

Topic	Key Findings
How do nutritional and dietary interventions affect psoriasis severity and symptoms?	- Supplementing with probiotics and prebiotics can improve disease activity and shift gut microbiota toward an anti-inflammatory profile in psoriasis patients, especially as adjuncts to topical therapy 1. - Adherence to low-calorie, Mediterranean, or vegetarian diets, and increased intake of omega-3 fatty acids, is associated with improved outcomes in psoriasis management 2 4.
What is the evidence for vitamin supplementation (especially vitamin D) in psoriasis treatment?	- Lower vitamin D levels are common in psoriasis, but oral vitamin D supplementation has shown inconsistent benefits; most studies do not find significant clinical improvement in large populations 3 4 5. - Oral vitamin D may benefit select patients (e.g., those with deficiency), but more research is needed to clarify efficacy, optimal dosing, and safety 4 5.
Can metabolic pathway modulation be an effective therapeutic approach for psoriasis?	- Most nutritional interventions studied to date target inflammation or gut microbiota; direct metabolic pathway modulation (as with pantethine's impact on cholesterol metabolism and immune cell function) is less commonly investigated but may offer new therapeutic possibilities 1 2. - Weight loss and healthy lifestyle changes have demonstrated benefits, possibly through metabolic effects 2 4.
Are nutritional interventions effective as standalone treatments for psoriasis?	- Existing evidence supports the use of dietary and supplement-based interventions primarily as adjuncts to conventional treatments, not as replacements 1 2 4. - Clinical guidelines emphasize that lifestyle and nutritional changes should accompany, rather than replace, standard psoriasis therapies 2 4.

How do nutritional and dietary interventions affect psoriasis severity and symptoms?

The new study’s finding that pantethine may improve psoriasis symptoms is broadly consistent with the literature showing benefits of certain dietary modifications and supplements as adjunctive treatments. Probiotics, prebiotics, and specific dietary patterns (such as the Mediterranean diet) have demonstrated positive effects on inflammation and disease activity, though the magnitude of benefit is generally modest and most pronounced when combined with standard therapies 1 2 4.

• Probiotic and prebiotic supplementation is associated with improved skin symptoms and favorable shifts in gut microbiota in psoriasis 1.
• Dietary interventions, particularly those reducing calories or increasing omega-3 fatty acid intake, support improved disease control 2 4.
• Benefits from nutritional interventions are most evident when used alongside conventional topical or systemic therapies 1 2.
• Weight loss and increased physical activity may further enhance outcomes by reducing systemic inflammation 2 4.

What is the evidence for vitamin supplementation (especially vitamin D) in psoriasis treatment?

While the new study explores pantethine (a vitamin B5 derivative), much of the existing research has focused on vitamin D. Although low vitamin D status is common among psoriasis patients, the literature does not consistently support oral vitamin D supplementation as an effective treatment for skin symptoms in the general patient population, with some benefit seen in those with deficiency 3 4 5.

• Randomized controlled trials generally do not show significant improvement in psoriasis severity with oral vitamin D supplementation 3.
• Topical vitamin D is effective for plaque-type psoriasis, but oral forms require further research to determine optimal dosing and efficacy 5.
• Supplementation may be helpful in patients with documented vitamin D deficiency, but routine use is not broadly recommended 4 5.
• Excessive vitamin D supplementation without deficiency has not shown clear clinical benefit and may carry risks 3 4.

Can metabolic pathway modulation be an effective therapeutic approach for psoriasis?

The new study’s focus on targeting metabolic processes within immune cells (specifically the Vanin-pantethine-cholesterol axis in dendritic cells) is a novel approach. Previous studies have primarily emphasized anti-inflammatory or microbiome-focused interventions rather than direct metabolic modulation. Weight loss and lifestyle interventions, which influence metabolic status, have shown benefits, suggesting that metabolic pathways are relevant but underexplored in psoriasis management 1 2 4.

• Metabolic interventions at the cellular level represent a new frontier, with limited but promising early evidence [new study].
• Diet and lifestyle changes that affect systemic metabolism, such as weight reduction, can improve psoriasis severity 2 4.
• The mechanism by which pantethine may act—altering cholesterol metabolism in immune cells—has not been the focus of previous clinical studies 1 2.
• There is a need for more research on how metabolic modulation can be harnessed therapeutically in psoriasis 2.

Are nutritional interventions effective as standalone treatments for psoriasis?

Current evidence supports nutritional interventions as complementary rather than primary treatments for psoriasis. Clinical guidelines consistently recommend using dietary and supplement-based strategies alongside standard therapies, not as substitutes. The new study’s findings fit within this paradigm, as pantethine was tested as an adjunct rather than a replacement for established treatments 1 2 4.

• Adjunctive use of nutritional interventions can enhance outcomes but is not sufficient alone for most patients 1 2 4.
• Lifestyle and dietary modifications may improve quality of life and support overall disease management, but conventional therapies remain essential 2 4.
• The role of supplements should be individualized based on patient characteristics and comorbidities 2.
• There is a consensus that physicians should guide patients on reliable, evidence-based dietary advice 2 4.

Future Research Questions

Despite promising early results, the clinical potential of pantethine and similar metabolic interventions in psoriasis remains uncertain. Key areas for future research include confirming efficacy in larger, more diverse patient populations, elucidating mechanisms, and determining optimal use alongside existing therapies. Addressing these questions will help clarify the place of metabolic and nutritional strategies in psoriasis management.

Research Question	Relevance
Does pantethine improve psoriasis symptoms in larger and more diverse populations?	The current study is limited by its small sample size; larger trials are needed to confirm findings and assess generalizability across different patient groups 1 2.
What are the mechanisms by which pantethine modulates immune cell activity in psoriasis?	Further research is required to clarify whether the clinical effects observed are directly related to the metabolic pathways identified in laboratory models 1.
Can metabolic modulation of dendritic cells be effectively targeted in other autoimmune diseases?	The study raises the possibility that similar metabolic pathways may contribute to other autoimmune conditions, warranting broader investigation 2.
How does pantethine compare to other nutritional supplements in psoriasis management?	Comparative effectiveness studies are needed to determine if pantethine offers distinct advantages or should be prioritized over other nutritional interventions, such as probiotics, omega-3s, or vitamin D 1 2 4.
What are the long-term safety and efficacy profiles of pantethine in psoriasis patients?	Long-term data on pantethine use in psoriasis are lacking; understanding sustained effects and potential risks is crucial for clinical recommendations 2 4.